Sanofi to Close Irish Plant

March 22, 2007
Pharmaceutical Technology Editors
ePT--the Electronic Newsletter of Pharmaceutical Technology

Paris (Mar. 15)-Sanofi-Aventis plans to close its manufacturing site in Waterford, Ireland.

Paris (Mar. 15)-Sanofi-Aventis (www.sanofi-aventis.com) plans to close its manufacturing site in Waterford, Ireland.

The company attributes the closure to increasing pressure from generics. Sanofi came to the decision after evaluating its plant network and concluding that other sites had excess capacity and could take over the manufacturing currently performed at the Waterford site with minimal extra investment.

The Waterford plant currently manufactures mature and over-the-counter products, including “Essentiale” for liver protection and “Flagyl” for microbial infections. Manufacture of these two products will be taken over by Sanofi plants in France and Germany.

The site is expected to close by the end of the year, with the loss of about 200 jobs.